The role of nitric oxide in the expression of renal aquaporin 2 in a cirrhotic rat model: Does an AVP-independent mechanism exist for the regulation of AQP2 expression?

Digestive Diseases and Sciences

Volumn 55, Issue 5, 2010, Pages 1296-1304

  Jun, Dae Won ^a   Park, Jin Hee ^a,b   Park, Yoo Sin ^b   Kang, Ju Seop ^b   Kim, Eun Kyung ^c   Kim, Kyung Tae ^d   Son, Byoung Kwan ^a   Kim, Seong Hwan ^a   Jo, Yun Ju ^a   Park, Young Sook ^a  

^a Eulji University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Eulji University   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Aquaporin; Cirrhosis; Nitric oxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AQUAPORIN 2; AQUAPORIN 3; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; CITRULLINE; CYCLIC GMP; ISOSORBIDE 5 NITRATE; ISOSORBIDE MONONITRATE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; SIMVASTATIN; STATIN; TETRAHYDROBIOPTERIN; THIOACETAMIDE; VASOPRESSIN; 5,6,7,8-TETRAHYDROBIOPTERIN; BIOPTERIN; DRUG DERIVATIVE; ISOSORBIDE DINITRATE; ISOSORBIDE-5-MONONITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY DISTAL TUBULE; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WISTAR RAT; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; ENZYME IMMUNOASSAY; KIDNEY; METABOLISM; NONPARAMETRIC TEST; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; AQUAPORIN 2; BIOPTERIN; CYCLIC GMP; DISEASE MODELS, ANIMAL; IMMUNOENZYME TECHNIQUES; ISOSORBIDE DINITRATE; KIDNEY; LIVER CIRRHOSIS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RANDOM ALLOCATION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIMVASTATIN; STATISTICS, NONPARAMETRIC; THIOACETAMIDE;

EID: 77953640395     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0852-y     Document Type: Article

References (28)

1. Koller H, Rosenkranz A. Hyponatremia to be an excellent predictor of outcome in patients with advanced cirrhosis. Liver Transpl. 2005;11:1001. doi:10.1002/lt.20468; author reply 1001-1002.
2. Londoño MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006;130:1135-1143. doi:10.1053/j.gastro. 2006.02.017.
3. Frigeri A, Gropper MA, Turck CW, et al. Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci USA. 1995;92:4328-4331. doi:10.1073/pnas.92.10.4328.
4. Nielsen S, DiGiovanni SR, Christensen EI, et al. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci USA. 1993;90:11663-11667. doi:10.1073/pnas.90.24.11663. (Pubitemid 24008699)
5. Fernández-Llama P. Aquaporins and renal water metabolism. Role in the physiopathology of water retention in cirrhosis. Gastroenterol Hepatol. 2001;24:205-209.
6. Asahina Y, Izumi N, Enomoto N, et al. Increased gene expression of water channel in cirrhotic rat kidneys. Hepatology. 1995;21:169-173. doi:10.1002/hep.1840210128.
7. Fujita N, Ishikawa SE, Sasaki S, et al. Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats. Am J Physiol. 1995;269:F926-F931.
8. Jonassen TE, Nielsen S, Christensen S, et al. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis. Am J Physiol. 1998;275:F216-F225.
9. Fernández-Llama P. Molecular bases for water/salt retention in experimental liver cirrhosis: aquaporins and renal sodium transporters. Nefrologia. 2002;22(Suppl 5):29-33.
10. Fernández-Llama P, Jimenez W, Bosch-Marcé M, et al. Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis. Kidney Int. 2000;58:216-228. doi:10.1046/j.1523-1755.2000.00156.x. (Pubitemid 30429866)
11. Esteva-Font C, Baccaro ME, Fernández-Llama P, et al. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: relationship with ascites and hepatorenal syndrome. Hepatology. 2006;44:1555-1563. doi:10.1002/hep.21414. (Pubitemid 44953660)
12. Ivarsen P, Frøkiaer J, Aagaard NK, et al. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis. Gut. 2003;52:1194-1199. doi:10.1136/gut.52.8.1194. (Pubitemid 36877435)
13. Pérez-Ayuso RM, Arroyo V, Camps J, et al. Effect of demeclocycline on renal function and urinary prostaglandin e2 and kallikrein in hyponatremic cirrhotics. Nephron. 1984;36:30-37. doi:10.1159/000183112.
14. Jiménez W, Gal CS, Ros J, et al. Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats. J Pharmacol Exp Ther. 2000;295:83-90.
15. Wong F, Blei AT, Blendis LM, et al. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology. 2003;37:182-191. doi:10.1053/jhep.2003.50021. (Pubitemid 36042159)
16. Ecelbarger CA, Nielsen S, Olson BR, et al. Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J Clin Invest. 1997;99:1852-1863. doi:10.1172/JCI119352.
17. Pedersen RS, Bentzen H, Bech JN, et al. Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Kidney Int. 2003;63:1417-1425. doi:10.1046/j.1523-1755.2003.00858.x. (Pubitemid 36350006)
18. Li X, Benjamin IS, Alexander B. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. J Hepatol. 2002;36:488-493. doi:10.1016/S0168-8278(02)00011-9. (Pubitemid 34407336)
19. Angeli P, Wong F, Watson H, Ginès P; CAPPS Investigators. Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology. 2006;44:1535-1542. doi:10.1002/hep.21412. (Pubitemid 44953659)
20. Gerbes AL, Gülberg V, Ginès P, et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology. 2003;124:933-939. doi:10.1053/gast.2003. 50143. (Pubitemid 36389796)
21. Bouley R, Breton S, Sun T, et al. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. J Clin Invest. 2000;106:1115-1126. doi:10.1172/JCI9594.
22. de Araujo M, Andrade L, Coimbra TM, et al. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. J Am Soc Nephrol. 2005;16:3339-3349. doi:10.1681/ASN.2004100832. (Pubitemid 46179337)
23. Forrest EH, Jones AL, Dillon JF, et al. The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol. 1995;23:254-258. doi:10.1016/0168-8278(95)80468-4.
24. Martin PY, Ginès P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med. 1998;339:533-541. doi:10.1056/NEJM199808203390807. (Pubitemid 28384887)
25. Martin PY, Ohara M, Gines P, et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest. 1998;101:235-242. doi:10.1172/JCI626.
26. Matei V, Rodríguez-Vilarrupla A, Deulofeu R, et al. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis. Hepatology. 2006;44:44-52. doi:10.1002/hep.21228. (Pubitemid 44055834)
27. Shah V, Toruner M, Haddad F, et al. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology. 1999;117:1222-1228. doi:10.1016/S0016- 5085(99)70408-7. (Pubitemid 29512682)
28. Yokomori H, Oda M, Ogi M, et al. Enhanced expression of endothelial nitric oxide synthase and caveolin-1 in human cirrhosis. Liver. 2002;22:150-158. doi:10.1034/j.1600-0676.2002.01588.x. (Pubitemid 34591257)